228246-76-2 Usage
Description
(S)-1-(1,2-DIHYDROACENAPHTHYLEN-1-YL)PIPERIDIN-4-ONE is a chemical compound belonging to the class of piperidin-4-one derivatives. It is a potential drug candidate with various pharmacological activities, making it a promising candidate for further research and development in the field of medicinal chemistry and drug discovery.
Uses
Used in Pharmaceutical Industry:
(S)-1-(1,2-DIHYDROACENAPHTHYLEN-1-YL)PIPERIDIN-4-ONE is used as a potential drug candidate for the treatment of neurological disorders such as Alzheimer's disease and Parkinson's disease. Its pharmacological activities make it a promising agent for further research and development in this field.
Used in Pain Management:
(S)-1-(1,2-DIHYDROACENAPHTHYLEN-1-YL)PIPERIDIN-4-ONE is used as a potential analgesic agent, indicating its potential use in pain management and treatment of various conditions that involve pain as a symptom.
Used in Anti-Inflammatory Applications:
(S)-1-(1,2-DIHYDROACENAPHTHYLEN-1-YL)PIPERIDIN-4-ONE is used as a potential anti-inflammatory agent, suggesting its possible application in the treatment of inflammatory conditions and diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 228246-76-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,8,2,4 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 228246-76:
(8*2)+(7*2)+(6*8)+(5*2)+(4*4)+(3*6)+(2*7)+(1*6)=142
142 % 10 = 2
So 228246-76-2 is a valid CAS Registry Number.
InChI:InChI=1/C17H17NO/c19-14-7-9-18(10-8-14)16-11-13-5-1-3-12-4-2-6-15(16)17(12)13/h1-6,16H,7-11H2/t16-/m0/s1
228246-76-2Relevant articles and documents
1,3,8-triazaspiro[4,5]decan-4-one derivatives
-
, (2008/06/13)
The present invention relates to compounds of the formula wherein R1 and R2 are each independently hydrogen, lower alkyl, lower alkoxy or halogen; R3 is phenyl, which is unsubstituted or substituted by lower alkyl, CF3, lower alkoxy or halogen; R4 is hydrogen, lower alkyl, lower alkenyl, -C(O)-lower alkyl, -C(O)-phenyl, lower alkyl-C(O)-phenyl, lower alkylene-C(O)O-lower alkyl, lower alkantriyl-di-C(O)O-lower alkyl, hydroxy-lower alkyl, lower alkyl-O-lower alkyl, lower alkyl-CH(OH)CF3, phenyl or benzyl, R5 and R6 are each independently hydrogen, phenyl, lower alkyl or di-lower alkyl or R5 and R6 together with the carbon atoms to which they are bound form a phenyl ring, or R5 and one of R1 or R2 together with the carbon atoms to which they are bound form a saturated or unsaturated 6 membered ring, A is a 4-7 membered saturated ring, their racemates and the enantiomers thereof, and the pharmaceutically acceptable acid addition salts thereof which are agonists and/or antagonists of the OFQ receptor.
